Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … Webb7 nov. 2024 · Phio Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024
PHIO / Phio Pharmaceuticals Corp - Institutional Ownership - fintel.io
WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save … how do they check your thyroid
Why did Phio Pharmaceuticals stock go up today? - MarketBeat
Webb8 apr. 2024 · MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO ), a clinical stage biotechnology company developing the next generation of therapeutics based on... WebbPhio Pharmaceuticals Our Science Our Science Overview Phio is addressing some of the biggest challenges in immuno-oncology (I/O) by developing therapeutics that leverage … WebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of … how do they choose a pope